In a trinitrobenzene sulfonic acid (TNBS)-induced colitis model, Il17ra-deficient mice were protected from colitis, and administration of an IL-17RA fusion protein ameliorated inflammation[40]. This evidence concerns the gene IL17RA and colitis.